Ajay Subramanian

7PUBLICATIONS
110CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunologyRadiation therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 05, 2026
Neoadjuvant BO-112 and Hypofractionated Radiation Therapy with or without Nivolumab in Soft-Tissue Sarcoma: Preclinical and Phase I Results.

Jie Deng, Aastha Pal, Stefano Testa

|Feb 12, 2026
Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcomes in Sarcoma.

Evan Rosenbaum, Fiona Ehrich, Mohammad Yosofvand

|Sep 26, 2025
Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphoma.

Ajay Subramanian, Shengqin Su, Jamie Flerlage

|Jan 14, 2025
Evolutionary Pressures Shape Undifferentiated Pleomorphic Sarcoma Development and Radiotherapy Response.

Erik S Blomain, Shaghayegh Soudi, Ziwei Wang

|May 31, 2024
Spatial phenotyping of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma.

Sheren Younes, Ajay Subramanian, Anum Khan

|Mar 01, 2024
Sarcoma microenvironment cell states and ecosystems are associated with prognosis and predict response to immunotherapy.

Ajay Subramanian, Neda Nemat-Gorgani, Timothy J Ellis-Caleo

Pageof 2

Frequent Collaborators

6 joint publications

Everett J Moding

3 joint publications

Neda Nemat-Gorgani

3 joint publications

Anusha Kalbasi

2 joint publications

Yasodha Natkunam